8,099
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Copper IUD continuation, unwanted effects and cost consequences at 1 year in users aged under 30 – a secondary analysis of the EURAS-IUD study

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 175-183 | Received 08 Dec 2020, Accepted 17 Jan 2021, Published online: 10 Mar 2021

References

  • United Nations Population Division. Contraceptive use by method 2019: data booklet. New York (NY): Department of Economic and Social Affairs; 2019.
  • United Nations Statistics Division. United Nations Demographic Yearbook. Fertility: Table 10 - Live births by age of mother and sex of child, general and age-specific fertility rates: latest available year, 2009–2018. New York (NY): Department of Economic and Social Affairs; 2019.
  • Heinemann K, Reed S, Moehner S, et al. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception. 2015;91(4):274–279..
  • Heinemann K, Reed S, Moehner S, et al. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception. 2015;91(4):280–283.
  • National Schedule of NHS Costs. 19 National cost collection data. 2018 [Accessed 2020 Aug 28]. Available from: https://www.england.nhs.uk/national-cost-collection/.
  • Unit Costs of Health and Social Care. University of Kent, Canterbury: personal social services research Unit (PSSRU); 2019 [Accessed 2020 Apr 21]. Available from: https://www.pssru.ac.uk/pub/uc/uc2019/services.pdf.
  • British National Formulary. BMJ Group and the Royal Pharmaceutical Society of Great Britain; 2020 [Accessed 2020 Mar 3]. Available from: https://bnf.nice.org.uk/medicinal-forms/intra-uterine-contraceptive-devices-copper.html.
  • Akintomide H, Barnes P, Brima N, et al. Higher discontinuation rate with a standard-sized compared to a small-sized 'gold standard' copper intrauterine device: a case-control review. BMJ Sex Reprod Health. 2019;45(4):263–268.
  • O'Brien P. The effects of increasing the copper load on IUD performance: a systematic review. Eur J Contracept Reprod Health Care. 2004;9(Suppl 1):93.
  • O'Brien P, Marfleet CC. Frameless versus classical intrauterine device for contraception. Cochrane Database of Syst Rev. 2005;(1):CD003282. DOI:10.1002/14651858.CD003282.pub2
  • Kulier R, O'Brien P, Helmerhorst FM, et al. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev. 2007;(4):CD005347. DOI:10.1002/14651858.CD005347.pub3
  • Mahajan R. Real world data: Additional source for making clinical decisions. Int J Appl Basic Med Res. 2015;5(2):82.
  • Cziraky M, Pollock M. Real-world evidence studies. Applied Clinical Trials; 2020 [Accessed 2020 Apr 22]. Available from: http://www.appliedclinicaltrialsonline.com/real-world-evidence-studies?pageID=1.
  • Heikinheimo O, Bitzer J, Garcia RL. Real-world research and the role of observational data in the field of gynaecology – a practical review. Eur J Contracept Reprod Health Care. 2017;22(4):250–259.
  • NHS Centre for Reviews and Dissemination, University of York. Preventing and reducing the adverse effects of unintended teenage pregnancies. Effective Health Care (Bulletin) 1997;3(1). ISSN: 0965–0288. Available from: https://www.york.ac.uk/media/crd/ehc31.pdf
  • Public Health England. Health promotion for sexual and reproductive health and HIV: strategic action plan, 2016 to 2019; 2015. Available from: https://www.gov.uk/government/publications/sexual-and-reproductive-health-and-hiv-strategic-action-plan
  • National Institute for Health and Care Excellence. NICE clinical guideline 30: long-acting reversible contraception; 2005 [updated July 2019]. Available from: https://www.nice.org.uk/guidance/cg30.
  • Country-by-Country Information. European Consortium for Emergency Contraception (ECEC); 2015 [Accessed 2020 Apr 22]. Available from: https://www.ec-ec.org/emergency-contraception-in-europe/country-by-country-information-2/.
  • Friedman JO. Factors associated with contraceptive satisfaction in adolescent women using the IUD. J Pediatr Adolesc Gynecol. 2015;28(1):38–42.
  • Sanders JN, Turok DK, Gawron LM, et al. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review. Am J Obstet Gynecol. 2017;216(6):590.e1–590.e8.
  • Bateson D, Harvey C, Trinh L, et al. User characteristics, experiences and continuation rates of copper intrauterine device use in a cohort of Australian women. Aust N Z J Obstet Gynaecol. 2016;56(6):655–661.
  • Dewan R, Bharti N, Mittal A, et al. Early IUD insertion after medically induced abortion. Eur J Contracept Reprod Health Care. 2018;23(3):231–236.
  • Jatlaoui TC, Riley HEM, Curtis KM. The safety of intrauterine devices among young women: a systematic review. Contraception. 2017;95(1):17–39.
  • Simonatto P, Bahamondes MV, Fernandes A, et al. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system. J Obstet Gynaecol Res. 2016;42(5):554–559.
  • Bachofner M, Blickenstorfer K, Hutmacher J, et al. Intrauterine device continuation rates and reasons for discontinuation in a Central European clinic with a high standard of care and ultrasound follow-up: a retrospective cohort study. Eur J Contracept Reprod Health Care. 2018;23(6):407–414.
  • Diedrich JT, Desai S, Zhao Q, et al. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. Am J Obstet Gynecol. 2015;212(1):50.e1–50.e8.
  • Schmidt EO, James A, Curran KM, et al. Adolescent experiences with intrauterine devices: a qualitative study. J Adolesc Health. 2015;57(4):381–386.
  • Chi IC. The multiload IUD-a U.S. researcher's evaluation of a European device. Contraception. 1992;46(5):407–425.
  • Wilson JC. A New Zealand randomized comparative study of three IUDs (Nova-T, MLCu375, MLAgCu250): 1-, 2- and 3-year results. Adv Contracept. 1992;8(2):153–159.
  • Khan SA, Amin Fouzia UZ, et al. A comparative trial of copper T 380 and Cu 375 IUCD. J Ayub Med Coll Abbottabad. 2010;22(3):185–187.
  • Nahidi F, Jalalinia S. Comparing the complications of 2 copper intrauterine devices: T380A and Cu-Safe 300. East Mediterr Health J. 2008;14(1):95–102.
  • Cox M, Tripp J, Blacksell S. Clinical performance of the Nova T380 intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plann Reprod Health Care. 2002;28(2):69–72.
  • Kriplani A, Sehgal R, Konar H, et al. A 1-year comparison of TCu380Ag versus TCu380A intrauterine contraceptive devices in India. Int J Gynaecol Obstet. 2019;145(3):268–277.
  • Haugan T, Skjeldestad FE, Halvorsen LE, et al. A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs. Contraception. 2007;75(3):171–176.
  • Kurz KH. Cavimeter uterine measurements and IUD clinical correlation. In: Zatuchni GI, Goldsmith A, Sciarra JJ, editors. Intrauterine contraception: advances and future prospects. Philadelphia: Harper and Row; 1984. p. 142–162.
  • Holm K, Mosfeldt Laursen E, Brocks V. Pubertal maturation of the internal genitalia: an ultrasound evaluation of 166 healthy girls. Ultrasound Obstet Gynecol. 1995;6(3):175–181.
  • Da Costa AG, Filho FM, Ferreira AC, et al. Uterine volume in adolescents. Ultrasound Med Biol. 2004;30(1):7–10.
  • Cole LP, Potts DM, Aranda C, et al. An evaluation of the TCu 380Ag and the Multiload Cu375. Fertil Steril. 1985;43(2):214–217.
  • Ragab A, Hamed HO, Alsammani MA, et al. Expulsion of Nova-T380, Multiload 375, and Copper-T380A contraceptive devices inserted during cesarean delivery. Int J Gynaecol Obstet. 2015;130(2):174–178.
  • Rasheed SM, Abdelmonem AM. Complications among adolescents using copper intrauterine contraceptive devices. Int J Gynaecol Obstet. 2011;115(3):269–272.
  • Escudero F, Gonzales GF, Delgadillo L, et al. Factors associated with discontinuation rates of the copper T380A IUD in a Peruvian public hospital. Adv Contracept. 1999;15(4):303–311.
  • Rivera R, Chen-Mok M, McMullen S. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD. Contraception. 1999;60(3):155–160.
  • Howard B, Grubb E, Lage MJ, et al. Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion. Reprod Health. 2017;14(1):70.
  • Ravi A, Prine L, Waltermaurer E, et al. Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network. J Am Board Fam Med. 2014;27(6):822–830.
  • Alton TM, Brock GN, Yang D, et al. Retrospective review of intrauterine device in adolescent and young women. J Pediatr Adolesc Gynecol. 2012;25(3):195–200.
  • Berenson AB, Tan A, Hirth JM, et al. Complications and continuation of intrauterine device use among commercially insured teenagers. Obstet Gynecol. 2013;121(5):951–958.
  • Akintomide H. Improving information on intrauterine contraception: providing advice in primary care. Br J Gen Pract. 2019;69(679):98–99.